Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

All Drugs for Transitional cell carcinoma (Page 2)

64 drugs are used for Transitional cell carcinoma.

Drug Brand Name Reports Deaths Hosp.
TRASTUZUMAB DERUXTECAN Enhertu 9 653 780
BACILLUS CALMETTE-GUERIN SUBSTRAIN CONNAUGHT LIVE ANTIGEN - 8 4 45
CABOZANTINIB S-MALATE CABOMETYX 8 4,203 6,193
IBRUTINIB Imbruvica 8 12,580 24,920
VINORELBINE Vinorelbine 8 840 1,790
DOCETAXEL\DOCETAXEL ANHYDROUS - 7 499 1,438
FLUOROURACIL FLUOROURACIL 7 6,997 20,941
COBIMETINIB Cotellic 6 527 1,895
EPIRUBICIN Ellence 6 2,212 5,603
ERLOTINIB Erlotinib 6 6,791 3,693
RAMUCIRUMAB CYRAMZA 6 1,444 2,066
AXITINIB INLYTA 5 3,141 4,050
CETRELIMAB - 5 2 21
OLAPARIB Lynparza 5 5,496 3,471
« 1 2